Life Extension Optimized Carnitine with GlycoCarn®, 60 vege caps (Expiry Jul 2018)

 Life Extension Optimized Carnitine with GlycoCarn®, 60 vege caps (Expiry Jul 2018) QR Code
  • Item No: C000916
  • Availability: In Stock
  • 70% OFF
    S$61.70

    S$18.51

  • Ex GST: S$17.30
    Pricing for shipping addresses out of Singapore
  • Expiry Date: Jul 2018

Pre Order Form

We will keep you posted on stock status.

Lower cellular energy production is an inevitable part of aging. Carnitine, an amino acid derivative, is found in nearly all cells of the body, promoting the burning of fatty acids for fuel in the mitochondria. Cellular energy production declines as we age. So Life Extension has developed state-of-the-art products that provide optimized, third generation forms of carnitine that help transport fatty acids right to the heart of your energy-producing mitochondria and produce cellular energy faster. This boost in cellular function can help provide a quicker recovery after exercise and less muscle fatigue during exercise.106,107 It may also benefit your brain, heart and central nervous system right along with your muscles.107-112

Optimized Carnitine with GlycoCarn® combines these three advanced forms of carnitine in one single formula to help you optimize your energy output:

• Acetyl-L-Carnitine crosses the blood-brain barrier to combat oxidative stress and promote energy production in brain and central nervous system tissues.109-112 It also supports the release and synthesis of acetylcholine, and enhances the release of dopamine from neurons and helps it bind to dopamine receptors.113-115

• ArginoCarn® is a patented form of acetyl-L-carnitine arginate dihydrochloride that is molecularly bonded to the amino acid arginine and known as the AminoCarnitine® generation. Cell studies suggest that it can promote the growth of neurites that facilitate communication among nerve cells in the brain.49

• Glycine Propionyl-L-Carnitine Hydrochloride (GlycoCarn®) is a patented form of AminoCarnitine® that is molecularly bonded to the amino acid glycine, one of the precursor amino acids to carnitine biosynthesis. This form offers such wide benefits as enhanced fatty acid metabolism, antioxidant activity and increased nitric oxide production.116 Recent research also shows support for those that participate in sports activities.117-123

Supplement Facts

Serving Size 2 vegetarian capsules

Servings Per Container 30

Amount Per Serving

Acetyl L-Carnitine HCl

800 mg

ArginoCarn® Acetyl L-Carnitine Arginate Di-HCl

300 mg

GlycoCarn® Glycine Propionyl L-Carnitine HCl

300 mg

Other ingredients: vegetable cellulose (capsule), dicalcium phosphate, stearic acid, silica.

Non-GMO

GlycoCarn® and ArginoCarn® are registered trademarks of Sigma-tau HealthScience, Inc. and are protected by Sigma-tau U.S. patent # 6,703,042 and worldwide patent EP1202956. The combination of multiple forms of Carnitine is protected by Sigma-tau patent # 6,245,378.

Dosage and Use
  • Take two (2) capsules once or twice daily, or as recommended by a healthcare practitioner.
  • This product can be taken on an empty stomach with water or juice in the morning in divided doses or all at once.
Warnings
  • KEEP OUT OF REACH OF CHILDREN
  • DO NOT EXCEED RECOMMENDED DOSE
  • Do not purchase if outer seal is broken or damaged.
  • When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

References

1. Ann N Y Acad Sci. 2004 Jun;1019:406-11.
2. Postepy Biochem. 2008;54(2):129-41.
3. Ann N Y Acad Sci. 2002 Apr;959:491-507.
4. Chang Gung Med J. 2009 Mar-Apr;32(2):113-32. 
5. Exp Biol Med (Maywood). 2007 May;232(5):592-606. 
6. Curr Aging Sci. 2008 Mar;1(1):10-21.
7. Biochim Biophys Acta. 2000 Jun 26;1486(1):1-17.
8. Acta Physiol Scand. 2003 Aug;178(4):385-90.
9. Int J Sports Med. 1998 May;19(4):231-44.
10. J Biol Chem. 2010. Jan 1;285:142-152. 
11. Alt Med Rev. 2009; 14(3):268-77. 
12. Entrez Gene: PARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha [ Homo sapiens ] GeneID: 10891. 
13. Entrez Gene: CREBBP CREB binding protein [ Homo sapiens ] GeneID: 1387. 
14. PLoS One. 2011;6(7):e21779. Epub 2011 Jul 21. 
15. Hormones (Athens). 2008 Apr-Jun;7(2):123-32.
16. Protein Pept Lett. 2008;15(4):385-91.
17. J Alzheimers Dis. 2007 May;11(2):229-40.
18. Ann N Y Acad Sci. 2006 May;1067:369-74.
19. Sci Aging Knowledge Environ. 2005 May 4;2005(18):pe12.
20. Life Sci. 2007 Nov 30;81(23-24):1602-14.
21. J Nutr. 2006 Jun;136(6):1517-21.
22. J Neuroinflammation. 2008 Sep 25;5:41. 
23. Immunology. 2005 Jul;115(3):375-87.
24. Am J Respir Crit Care Med. 2002 Mar 15;165(6):818-23. 
25. Eur J Pharmacol. 2006 Jul 10;541(1-2):95-105.
26. Neurosci Lett. 2008 Dec 26;448(2):175-9.
27. Biochimie. 2011 Mar;93(3):506-12.
28. J Pharmacol Exp Ther. 2011 Sep;338(3):1013-22
29. Int J Neurosci. 2011 Jun;121(6):329-36. 
30. Nat Med. 2003 Mar;9(3):294-9.
31. J Am Soc Nephrol. 2011 May;22(5):914-26. 
32. Pharmacol Res. 2010 Jun;61(6):482-8. 
33. Diabetes Care. 2006 Sep;29(9):2064-71.
34. Circ Heart Fail. 2010 Mar;3(2):294-305. 
35. Acta Diabetol. 2001;38(3):135-8.
36. Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):371-7
37. Ann N Y Acad Sci. 2008 Apr;1126:288-90. 
38. J Lipid Res. 2006 May; 47(5): 964-74
39. J Am Soc Nephrol. 2005 Jan;16(1):144-50.
40. Life Sci. 1988;43(21):1725-31.
41. Altern Med Rev. 2007 Dec;12(4):343-51.
42. FASEB J. 1999 Feb;13(2):411-8.
43. Antioxid Redox Signal. 2000 Fall;2(3):473-83.
44. FASEB J. 2001 Mar;15(3):700-6. 
45. Arch Biochem Biophys. 2004 Mar 1;423(1):126-35.
46. Redox Rep. 2005;10(1):52-60.
47. Altern Med Rev. 2005 Dec;10(4):268-93.
48. Neurosci Lett. 1994 Jan 3;165(1-2):33-6.
49. Neurochem Res. 1995 Jan;20(1):1-9.
50. Rejuvenation Res. 2009 Dec;12(6):421-34. 
51. Lancet. 1989 Mar 25;1(8639):642-5. 
52. Curr Opin Clin Nutr Metab Care. 2010 Sep;13(5):511-7.
53. Age (Dordr). 2010 Sep;32(3):337-46.
54. Ageing Res Rev. 2011 Apr;10(2):238-52.
55. Eur J Neurosci. 2002 Sep;16(6):1015-24.
56. Nature. 2003 Apr 24;422(6934):832.
57. Connect Tissue Res. 1993;29(2):153-61.
58. Commun Integr Biol. 2011 Sep;4(5):627-9.
59. Cell Mol Life Sci. 2010 Oct;67(20):3435-47.
60. Zhonghua Yi Xue Za Zhi (Taipei). 2001 May;64(5):259-70.
61. Cardiovasc Drugs Ther. 2004 Nov;18(6):421-31. 
62. J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):119-28.
63. Biochem Biophys Res Commun. 2007 Nov 16;363(2):257-62.
64. J Clin Biochem Nutr. 2008 January; 42(1): 29–34. 
65. FOOD Style. 2009;21:13(7)50-3. 
66. J Nutr. 2006 Feb;136(2):390-6.
67. J Am Coll Nutr. 2001 Dec;20(6):591-8.
68. Free Radic Res. 2002 Apr;36(4):445-53.
69. Int J Biochem Cell Biol. 2005 Jun;37(6):1208-18. 
70. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8892-7.
71. Neurobiol Dis. 2005 Apr;18(3):618-27. 
72. J Mol Neurosci. 2006;28(2):125-41. 
73. Brain Res Bull. 2006 Jun 15;70(1):22-32. 
74. FEBS Lett. 1999 Jan 25;443(2):163-6.
75. Eur Heart J. 2006 Nov;27(22):2675-81.
76. Biofactors. 2005;25(1-4):137-45.
77. Mol Biotechnol. 2007 Sep;37(1):31-7.
78. Systemic CoQ level in animals: Part II. Unpublished study. Natreon, Inc.; 2007.
79. Pharmacologyonline. 2009;1:817-25. 
80. Pharmacologyonline. 2009;2:690-8.
81. Electronic Journal of Biotechnology. 2008 Jul 15;11(3).
82. Ghosal S. Shilajit in Perspective. Alpha Science International Limited; 2006.
83. Kaneka Corp. Unpublished study. 2007.
84. Sci Total Environ. 1987 Apr;62:347-54.
85. Environ Sci Technol. 2002 Jul 15;36(14):3170-5.
86. Environ Sci Technol. 2002 May 1;36(9):1939-46.
87. Environ Sci Technol. 2009 Feb 1;43(3):878-83.
88. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28.
89. KANEKA CORP. Anti-fatigue effect in rats. Unpublished data, Kaneka Corp.
90. Exp Gerontol. 2006 Feb;41(2):130-40.
91. Ubiquinol has a higher bioavailability compared to ubiquinone. Unpublished data, Kaneka Corp.
92. Plasma levels of COQ10 for ubiquinol increased dose dependently. Unpublished data, Kaneka Corp.
93. LEF internal unpublished study 2006
94. Skin Pharmacol. 1994;7(5):278-84.
95. Circulation. 2008 Jan 22;117(3):421-8. Epub 2007 Dec 24.
96. Wien Klin Wochenschr. 2006 Mar;118(3-4):100-7.
97. Eur J Pharm Sci. 1999 Apr;8(1):57-65.
98. Free Radic Res. 2004 Oct;38(10):1083-92.
99. Biochem Mol Biol Int. 1998 Oct;46(3):585-95.
100. Am J Physiol. 1997 Jul;273(1 Pt 1):E185-E191.
101. Biochem Pharmacol. 1996 Feb 9;51(3):233-8.
102. J Mol Cell Cardiol. 1995 Sep;27(9):1895-903.
103. Z Naturforsch [C]. 1994 Sep-Oct;49(9-10):691-2.
104. Carlson DA, et al. Lipoic Acid: Energy Production, Antioxidant Activity and Health Effects. Taylor & Francis Publishers; 2008:235-70.
105. Altern Med Rev. 2007; 12(4):343-51.
106. Int J Sport Nutr Exerc Metab.2008 Feb;18(1):19-36.
107. J Physiol. 2007 Jun 1;581(Pt 2):431-44. 
108. Exp Physiol. 2008 Oct;93(10):1139-46.
109. Mol Aspects Med. 2004 Oct-Dec;25(5-6):533-49.
110. Clin Exp Pharmacol Physiol. 2006 Aug;33(8):725-33.
111. Neuropharmacology. 2008 Aug;55(2):223-9.
112. Neuropharmacology. 2006 Jun;50(8):917-23.
113. J Neurosci Res. 1991 Nov;30(3):555-9.
114. Neurochem Res. 1993 May;18(5):573-8.
115. Mol Cell Biochem.2003 Dec;254(1-2):227-34
116. J Int Soc Sports Nutr. 2007 Dec 3;4:22. 
117. Int J Sport Nutr Exerc Metab. 2008 Feb;18(1):19-36. 
118. Res Sports Med. 2009 Jan-Mar;17(1):1-16. 
119. J Int Soc Sports Nutr. 2009 Apr 2;6:9.
120. Int J Vitam Nutr Res. 2009 May;79(3):131-41. 
121. J Int Soc Sports Nutr. 2010 May 6;7:16. 
122. Int J Vitam Nutr Res. 2010 Jan;80(1):12-23. 
123. J Int Soc Sports Nutr. 2010 Oct 28;7:35. 
124. Neurochem Res. 2009 Jun;34(6):1021-9.
125. Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Jun;28(3):113-20.
126. Mol Aspects Med. 2004 Oct-Dec;25(5-6):551-67.
127. Ann N Y Acad Sci. 2002 Apr;959:491-507.
128. J Appl Physiol. 1999 Apr;86(4):1191-6.
129. Chem Biol Interact. 2006 Nov 7;163(3):192-8.
130. Nutrition. 2007 Jan;23(1):76-80.
131. Am J Physiol Cell Physiol. 2007 Oct;293(4):C1395-403.
132. Pharmacol Ther. 2007 Jan;113(1):154-64.
133. Toxicol Lett. 2005 Dec 30;160(1):1-7.
134. Chem Biol Interact. 2004 Apr 15;147(3):259-71.
135. Chem Biol Interact. 2001 Nov 28;138(2):189-98.
136. Neurochem Res. 2007 Sep;32(9):1552-8
137. Drug Metab Rev. 1998 May;30(2):245-75.
138. Free Radic Biol Med. 1997;22(1-2):359-78.
139. Free Radic Biol Med. 2001 Jul 1;31(1):53-61.
140. Z Naturforsch [C]. 1998 Mar-Apr;53(3-4):250-3.
141. Nutrition. 2001 Oct;17(10):888-95.
142. Gen Pharmacol. 1997 Sep;29(3):315-31.
143. Biochim Biophys Acta 1988 Dec 16;963(3):558-61
144. Biochem Biophys Res Commun 1990 Jun 29;169(3):851-7

Write a review

Please login or register to review

Related Products

Tags: life, extension, optimized, carnitine, with, glycocarn®, vege, caps, sports, performance